WCBA
FPRX

Weaver C. Barksdale & Associates’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio FPRX Stock Details FPRX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-56
Closed -$2K – 506
2017
Q2 		$2K Hold
56
– – ﹤0.01% 485
2017
Q1 		$2K Hold
56
– – ﹤0.01% 485
2016
Q4 		$3K Hold
56
– – ﹤0.01% 463
2016
Q3 		$3K Buy
+56
New +$3K 0.01% 453